SCHEMBL25369585

SCHEMBL25369585

C[C@]1(O)CCc2c(ccc3ccccc23)O1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.46
▸ HPGD P15428 4/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ CYP2C19 P33261 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ GLA P06280 2/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ SIRT1 Q96EB6 1/20 0.46
▸ MAPT P10636 2/20 0.41
▸ ALDH1A1 P00352 3/20 0.39
▸ HTT P42858 2/20 0.39
▸ CDK5 Q00535 1/20 0.39
▸ CDK5R1 Q15078 1/20 0.39
▸ NCOA1 Q15788 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ NCOA3 Q9Y6Q9 1/20 0.39
▸ ALOX15 P16050 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ LMNA P02545 1/20 0.36
▸ GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30588898 1.00 KDM4E (0.46) KDM4EHPGDCYP1A2CYP2C19HSD17B10
SCHEMBL8723458 0.84 HPGD (0.49) KDM4EHPGDCYP1A2CYP2C19HSD17B10
SCHEMBL6659911 0.75 KDM4E (0.46) KDM4EHPGDCYP1A2CYP2C19HSD17B10
SCHEMBL18029940 0.73 KDM4E (0.46) KDM4EHPGDCYP1A2CYP2C19HSD17B10
SCHEMBL4152628 0.69 SIGMAR1 (0.43) ALDH1A1SIGMAR1
SCHEMBL30830197 0.67 KDM4E (0.56) KDM4EHPGDCYP1A2CYP2C19HSD17B10
SCHEMBL7473565 0.67 KDM4E (0.56) KDM4EHPGDCYP1A2CYP2C19HSD17B10
Water SCHEMBL16634424 0.66 KDM4E (0.54) KDM4EHPGDCYP1A2CYP2C19HSD17B10
Acetic Acid SCHEMBL11711913 0.66 KDM4E (0.50) KDM4EHPGDCYP1A2CYP2C19HSD17B10
SCHEMBL371993 0.65 KDM4E (0.53) KDM4EHPGDCYP1A2CYP2C19HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230272401-A1 COMPOSITIONS FOR FLCN GENE MODULATION AND METHODS THEREOF Genetic Intelligence, Inc 2023-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230272401-A1 COMPOSITIONS FOR FLCN GENE MODULATION AND METHODS THEREOF TARDBP, FUS, RBM17 KDM4E 2645/4885HPGD 4703/4885CYP1A2 4841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback